Your browser doesn't support javascript.
loading
Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy.
Ababneh, Hazim S; Frigault, Matthew J; Ng, Andrea K; Patel, Chirayu G.
Afiliação
  • Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Frigault MJ; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ng AK; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hematol Oncol ; 42(1): e3243, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38103211

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Linfoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Linfoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article